CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Determining what age to move from stocks to bonds is vital for long-term financial health. Explore guidelines to help you plan your investment strategy.
23,118 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Two heavyweights square off in the Bitcoin ETF arena: IBIT and FBTC. Both hold spot Bitcoin and charge 0.25%, but the...
Elon Musk has floated a colossal Terafab project aimed at dramatically scaling U.S. chip production from a single pla...
Shiba (SHIB) has entered a difficult period, with prices down roughly 65% over the past year and on-chain activity co...
A high-profile nod from a tech legend can spark instant moves in AI chip stocks. This guide explains how to separate ...
A major tech giant has locked in a multi-year AI compute deal worth nearly $1 billion per month for Nvidia GPUs, outp...
iQIYI is betting on AI to revive growth as its core subscription business falters. With Nadou Pro signing thousands o...
Dell Technologies beat on revenue with a strong AI server push, while Super Micro Computer posted healthy growth that...
Federal authorities executed a search warrant at a Southern California aerospace site after a chemical tank overheate...
Investors are watching Redwire as a multifaceted space tech company. This article explains how redwire's space busine...
A legendary investor speculates SpaceX could reach $30 trillion by 2040. This piece breaks down what that would requi...
Super Micro Computer stunned investors with a colossal AI server backlog, but a planned $7 billion capital raise trig...